CENTOCOR, INC.

🇺🇸United States
Ownership
Subsidiary
Employees
1.2K
Market Cap
-
Website
http://www.centocor.com
Clinical Trials
Related News

A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma

Phase 2
Completed
Conditions
Asthma
Interventions
Drug: CNTO148
Drug: Placebo
First Posted Date
2005-09-21
Last Posted Date
2012-08-20
Lead Sponsor
Centocor, Inc.
Target Recruit Count
309
Registration Number
NCT00207740

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

Phase 3
Completed
Conditions
Crohn Disease
First Posted Date
2005-09-21
Last Posted Date
2010-04-27
Lead Sponsor
Centocor, Inc.
Target Recruit Count
580
Registration Number
NCT00207662

A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis

Phase 3
Completed
Conditions
Psoriasis
First Posted Date
2005-04-01
Last Posted Date
2011-05-19
Lead Sponsor
Centocor, Inc.
Target Recruit Count
378
Registration Number
NCT00106834

A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis

Phase 3
Completed
Conditions
Psoriasis
Parapsoriasis
First Posted Date
2005-04-01
Last Posted Date
2011-05-17
Lead Sponsor
Centocor, Inc.
Target Recruit Count
683
Registration Number
NCT00106847

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis

Phase 3
Completed
Conditions
Ulcerative Colitis
First Posted Date
2004-11-15
Last Posted Date
2011-05-17
Lead Sponsor
Centocor, Inc.
Target Recruit Count
364
Registration Number
NCT00096655

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis

Phase 2
Terminated
Conditions
Giant Cell Arteritis
First Posted Date
2004-02-04
Last Posted Date
2011-05-17
Lead Sponsor
Centocor, Inc.
Target Recruit Count
44
Registration Number
NCT00076726

A Study of Infliximab in Patients With Sarcoidosis

Phase 3
Completed
Conditions
Sarcoidosis
First Posted Date
2003-11-24
Last Posted Date
2011-05-17
Lead Sponsor
Centocor, Inc.
Target Recruit Count
139
Registration Number
NCT00073437

A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)

First Posted Date
2003-11-21
Last Posted Date
2011-05-17
Lead Sponsor
Centocor, Inc.
Target Recruit Count
808
Registration Number
NCT00073372

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

Phase 2
Completed
Conditions
Cachexia
Pancreatic Neoplasms
First Posted Date
2003-05-08
Last Posted Date
2011-05-17
Lead Sponsor
Centocor, Inc.
Target Recruit Count
73
Registration Number
NCT00060502

A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD

First Posted Date
2003-03-10
Last Posted Date
2011-05-17
Lead Sponsor
Centocor, Inc.
Target Recruit Count
234
Registration Number
NCT00056264
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy